David Granot's Net Worth
$1.7 Million
Who is David Granot?
David Granot has an estimated net worth of $1.7 Million. This is based on reported shares across multiple companies, which include ORMAT TECHNOLOGIES, INC., and Protalix BioTherapeutics, Inc..
SEC CIK
David Granot's CIK is 0001551620
Past Insider Trading and Trends
2015 was David Granot's most active year for acquiring shares with 6 total transactions. David Granot's most active month to acquire stocks was the month of October. 2022 was David Granot's most active year for disposing of shares, totalling 14 transactions. David Granot's most active month to dispose stocks was the month of October. 2019 saw David Granot paying a total of $642,750.00 for 21,116 shares, this is the most they've acquired in one year. In 2019 David Granot cashed out on 37,033 shares for a total of $1,064,001.67, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ORMAT TECHNOLOGIES, INC. (ORA) Snapshot price: $65.1
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -12.43% | -686.00 |
$73.46 | -$50,393.56 | 4.83K |
May 30
| |||
Form 4
| +35.54% | 1.45K |
—
|
—
| 5.52K |
May 8 - May 9
| |||
Form 4
| -7.12% | -312.00 |
$64.69 | -$20,183.28 | 4.07K |
Nov 17
| |||
Form 4
| +16.57% | 623 |
—
|
—
| 4.38K |
Nov 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
| -16.50% | -743.00 |
$101.00 | -$75,043.00 | 3.76K |
Nov 7
| |||
Form 4
| +54.11% | 1.58K |
—
|
—
| 4.5K |
Nov 2 - Nov 3
| |||
Form 4/A
|
—
|
0
|
$74.36 | -$68,728.69 | 2.92K |
Aug 25
| |||
Form 4/A
|
—
|
0
|
$77.91 | -$39,624.35 | 2.92K |
Aug 24
| |||
Form 4
|
—
|
0
|
$74.70 | -$69,828.06 | 2.92K |
Aug 25
| |||
Form 4
|
—
|
0
|
$78.91 | -$42,355.91 | 2.92K |
Aug 24
| |||
Form 4
| -18.70% | -672.00 |
$79.64 | -$53,518.08 | 2.92K |
Nov 10
| |||
Form 4
| +31.04% | 1.43K |
—
|
—
| 6.04K |
Nov 3 - Nov 4
| |||
Form 4
| +138.33% | 1.26K |
—
|
—
| 2.16K |
Nov 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 4
| |||
Form 4/A
|
∞
| 908 |
$77.51 | -$71,076.67 | 908 |
Nov 7
| |||
Form 4
|
∞
| 1.82K |
—
|
—
| 1.82K |
Nov 7
| |||
Form 4
|
—
|
0
|
$59.08 | -$174,300.00 | 1.36K |
Aug 12
| |||
Form 4
|
—
|
0
|
$49.97 | -$175,875.00 |
0
|
Jun 7
| |||
Form 4
| -100.00% | -759.00 |
$54.00 | -$40,986.00 |
0
|
Nov 26
| |||
Form 4
|
∞
| 759 |
$51.98 | -$39,868.66 | 759 |
Nov 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 7
| |||
Form 4
|
—
|
0
|
$42.95 | -$73,575.00 |
0
|
Sep 14
| |||
Form 4
|
—
|
0
|
$42.97 | -$147,350.00 |
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 7
| |||
Form 4
|
—
|
0
|
$37.49 | -$75,495.00 |
0
|
Aug 8
| |||
Form 4
|
—
|
0
|
$33.30 | -$52,800.00 |
0
|
Mar 9
| |||
Form 4
|
—
|
0
|
$27.53 | -$22,425.00 |
0
|
Nov 24
| |||
Form 4
|
—
|
0
|
$27.33 | -$26,310.00 |
0
|
Nov 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 3
| |||
Form 4
|
—
|
0
|
$27.59 | -$18,050.00 |
0
|
Sep 21
| |||
Form 4
|
—
|
0
|
$28.85 | -$68,662.50 |
0
|
Aug 2 - May 21
| |||
Form 4
|
—
|
0
|
$27.14 | -$55,837.50 |
0
|
Mar 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 6
| |||
Form 4
|
—
|
0
|
$22.40 | -$20,325.00 |
0
|
Aug 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Protalix BioTherapeutics, Inc. (PLX) Snapshot price: $1.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||